CoChat

Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation

Open access
Yang, Shenghong, Imamura, Yu, Jenkins, Russell W., Cañadas, Israel, Kitajima, Shunsuke, Aref, Amir, Brannon, Arthur, Oki, Eiji, Castoreno, Adam, Zhu, Zehua, Thai, Tran, Reibel, Jacob, Qian, Zhirong, Ogino, Shuji, Wong, Kwok K., Baba, Hideo, Kimmelman, Alec C., Pasca Di Magliano, Marina, Barbie, David A. · 2016 · Cancer Immunology Research
Cited by 89

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Autophagy promotes tumor progression downstream of oncogenic KRAS, yet also restrains inflammation and dysplasia through mechanisms that remain incompletely characterized. Understanding the basis of this paradox has important implications for the optimal targeting of autophagy in cancer. Using a mouse model of cerulein-induced pancreatitis, we found that loss of autophagy by deletion of Atg5 enhanced activation of the IκB kinase (IKK)-related kinase TBK1 in vivo, associated with increased neutrophil and T-cell infiltration and PD-L1 upregulation. Consistent with this observation, pharmacologic or genetic inhibition of autophagy in pancreatic ductal adenocarcinoma cells, including suppression of the autophagy receptors NDP52 or p62, prolonged TBK1 activation and increased expression of CCL5, IL6, and several other T-cell and neutrophil chemotactic cytokines in vitro. Defective autophagy also promoted PD-L1 upregulation, which is particularly pronounced downstream of IFNγ signaling and involves JAK pathway activation. Treatment with the TBK1/IKKϵ/JAK inhibitor CYT387 (also known as momelotinib) not only inhibits autophagy, but also suppresses this feedback inflammation and reduces PD-L1 expression, limiting KRAS-driven pancreatic dysplasia. These findings could contribute to the dual role of autophagy in oncogenesis and have important consequences for its therapeutic targeting. Cancer Immunol Res; 4(6); 520–30. ©2016 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2326-6066.cir-15-0235

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 89

Metadata

Authors
Yang, S., Imamura, Y., Jenkins, R. W., Cañadas, I., Kitajima, S., Aref, A., Brannon, A., Oki, E., Castoreno, A., Zhu, Z., Thai, T., Reibel, J., Qian, Z., Ogino, S., Wong, K. K., Baba, H., Kimmelman, A. C., Pasca Di Magliano, M., & Barbie, D. A.
Venue
Cancer Immunology Research
Published
2016-05-31
Volume
4
Issue
6
Pages
520-530
ISSN
  • 2326-6066 (ISSN-L)
  • 2326-6074
OpenAlex
W2331975416
Cited by
89
References
17
FWCI
7.90
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation. https://app.cochat.ai/papers/10.1158/2326-6066.cir-15-0235
The paper
Yang, S., Imamura, Y., Jenkins, R. W., Cañadas, I., Kitajima, S., Aref, A., Brannon, A., Oki, E., Castoreno, A., Zhu, Z., Thai, T., Reibel, J., Qian, Z., Ogino, S., Wong, K. K., Baba, H., Kimmelman, A. C., Pasca Di Magliano, M., & Barbie, D. A. (2016). Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-15-0235

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.